US and Canada markets are closed on Monday Sept 2. So after close on Friday 8/30, markets will next open on Tuesday 9/3. By this time, all of the upcoming Resverlogix ESC presentations will be done. The  ESC Resverlogix symposium on Saturday 8/31 will have concluded. The ESC poster for the BETonMACE design, rationale and baseline data will have been presented by Dr. Kausik Ray on Monday 9/2. And the ESC poster on apabetalone effects on vascular inflammation, calcification and plaque vulnerability will have been presented by Dr. Ewelina Kulikowski by the time markets open on Tuesday 9/3 (Paris is several hours ahead of us on the other side of the lake). When markets open back up again on Tuesday September 3, we will be into the hot-zone of expected top-line data Sept 2019. Tick tock.

https://www.resverlogix.com/investors/news.html?article=641

https://pace-cme.org/2019/07/03/epigenetics-a-new-pathway-to-tackle-residual-risk/

https://esc365.escardio.org/Congress/ESC-CONGRESS-2019/Poster-Session-5-Acute-coronary-syndrome-treatment/198781-bet-inhibition-with-apabetalone-in-post-acs-patients-with-diabetes-design-and-baseline-characteristics-of-the-betonmace-trial

https://esc365.escardio.org/Congress/ESC-CONGRESS-2019/Poster-Session-6-Coronary-artery-disease-inflammation/199379-apabetalone-rvx-208-inhibits-key-drivers-of-vascular-inflammation-calcification-and-plaque-vulnerability-through-a-bet-dependent-epigenetic-mechanism

Also FYI the links above to the ESC posters now include the abstracts.

BearDownAZ